Abiopharma

RedHill Biopharma - RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders Equity Requirement

Bausch Health Notification

Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference

ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference

Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference

RedHill Biopharma Successfully Regains Compliance with Nasdaq Stockholders Equity Requirement

Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers

Cullinan Therapeutics Receives FDA Fast Track Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia

Q32 Bio Sells Complement Inhibitor ADX-097

Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition